Skip to main content
. Author manuscript; available in PMC: 2019 Jul 10.
Published in final edited form as: Psychol Med. 2017 Oct 17;48(10):1624–1633. doi: 10.1017/S0033291717003105

Table 3.

Adjusted odds of onset and persistence of post-deployment AUD/SUD among Army STARRS Pre/Post Deployment Study respondents

Adjusted Odds Ratio (95% CI)
Incidence of AUD/SUD post-deployment (n=3729) Persistence of AUD/SUD from pre- to post-deployment (n=916)
Any AUD/SUD Chronic AUD/SUD1 Any AUD/SUD Chronic AUD/SUD1
Pre-deployment factors (assessed at T0)
Number of prior deployments
 Zero 1.00 1.00 1.00 1.00
 One 0.57 (0.30–1.05) 0.52 (0.27–1.01) 0.94 (0.64–1.40) 1.05 (0.63–1.73)
 Two or more 0.81 (0.40–1.65) 0.58 (0.27–1.25) 0.72 (0.50–1.04) 0.84 (0.55–1.28)
 Wald X2(2) 3.40 4.47 3.02 0.86
Past-month binge drinking 1.85 (1.27–2.70) 1.93 (1.26–2.95) - -
 Wald X2(1) 10.30** 9.09** - -
Past-month PTSD, MDE, GAD, or SI 0.77 (0.38–1.58) 0.54 (0.24–1.22) 0.84 (0.44–1.62) 1.06 (0.52–2.13)
 Wald X2(1) 0.50 2.22 0.27 0.02
  Peri-deployment factors (assessed at T1)
Combat/deployment stress (standardized) 1.22 (0.96–1.55) 1.29 (0.97–1.70) 1.05 (0.90–1.23) 1.12 (0.96–1.30)
 Wald X2(1) 2.61 3.07 0.34 1.96
Personal life stress (standardized) 1.54 (1.25–1.89) 1.72 (1.41–2.09) 1.19 (0.99–1.44) 1.30 (1.08–1.56)
 Wald X2(1) 16.99*** 28.48*** 3.49 7.80**
Military life stress (standardized) 1.02 (0.89–1.16) 1.06 (0.83–1.35) 1.20 (1.02–1.41) 1.07 (0.89–1.27)
 Wald X2(1) 0.08 0.22 5.04* 0.49
PTSD symptoms (standardized) 1.04 (0.77–1.40) 0.94 (0.64–1.37) 0.93 (0.72–1.20) 0.87 (0.65–1.16)
 Wald X2(1) 0.07 0.11 0.35 0.88
MDE/GAD symptoms (standardized) 1.01 (0.72–1.42) 0.99 (0.69–1.44) 1.23 (0.90–1.70) 1.24 (0.92–1.68)
 Wald X2(1) 0.00 0.00 1.69 1.97

Note. AUD/SUD=Alcohol or Substance Use Disorder; CI=confidence interval; PTSD=posttraumatic stress disorder; MDE=major depressive episode; GAD=generalized anxiety disorder; SI=suicidal ideation. Each column displays the results for a separate weights-adjusted logistic regression model. To streamline the table, soldier characteristics included in the models (age, sex, race, ethnicity, education, and marital status) are omitted; none displayed significant associations with incidence or persistence of AUD/SUD (ps>.10). Models also adjusted for Brigade Combat Team. Significant adjusted odds ratios (where the overall Wald X2 test is also statistically significant) appear in bold.

*

p<.05;

**

p<.005;

***

p<.0005.

1

Chronic AUD/SUD was defined as the disorder being present at both 3 months and 9 months post-deployment (i.e., at both T2 and T3).